Skip to main content

RIASTAP 1 g Injectable solution

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(38)

Andrei Popov

General medicinePain medicine7 years of experience

Dr. Andrei Popov is a General Practitioner with specialized training in chronic pain. He provides online consultations for adult patients in Spain and other European countries.

Dr. Popov understands that seeking help with weight-related concerns or pain that has persisted for months can be difficult. Many patients come to him after trying different approaches without feeling truly heard. During the consultation, the doctor creates a comfortable and supportive, non-judgmental environment where the patient’s medical history can be discussed in detail, questions can be answered, and the next steps can be decided together.

Weight Management and Metabolic Health

Dr. Popov can help assess overweight, obesity, and related conditions such as hypertension, diabetes, or metabolic disorders. During the consultation, the patient’s medical history, test results, current medications, and previous treatments will be reviewed.

If you would like to learn about possible medication options or have already started treatment, the doctor can assess your situation, review the effectiveness and tolerability of the therapy, and clearly explain its benefits, potential risks, and alternatives.

Not every patient requires the same treatment. A consultation does not guarantee a prescription — it provides an objective medical assessment and a plan tailored to your individual situation.

Pain and General Medicine

You can also consult Dr. Popov regarding:

* chronic pain, migraines, neuralgia, and fibromyalgia;

* back, neck, lower back, or joint pain;

* hypertension, diabetes, and follow-up of chronic conditions;

* review of test results, medical reports, and current treatment;

* preventive medicine and a second medical opinion.

How the Consultation Works

The video consultation lasts up to 30 minutes. The doctor will listen carefully, review the information you provide, and explain the next steps in clear and understandable language.

If additional tests, an in-person consultation, or urgent medical care are required, the doctor will inform you directly.

Dr. Popov’s goal is to make sure the patient feels heard and leaves the consultation with a clear understanding of their condition and the next steps they can take.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use RIASTAP 1 g POWDER FOR INJECTABLE SOLUTION OR INFUSION

Contents of the leaflet

  1. Introduction
  2. What is Riastap and what is it used for
  3. What you need to know before you use Riastap
  4. How to use Riastap
  5. Possible side effects
  6. Storage of Riastap
  7. Further information

Introduction

Package Leaflet: Information for the User

Riastap 1g

Powder for solution for injection and infusion

Human fibrinogen

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Riastap and what is it used for
  2. What you need to know before you use Riastap
  3. How to use Riastap
  4. Possible side effects
  5. Storage of Riastap
  6. Contents of the pack and other information

1. What is Riastap and what is it used for

What is Riastap?

Riastap contains human fibrinogen, which is an important protein for blood clotting. The lack of fibrinogen means that the blood does not clot as quickly as it should, leading to an increased tendency to bleed. Replacement of human fibrinogen with Riastap repairs the clotting mechanism.

What is Riastap used for?

Riastap is used to treat bleeding in patients with congenital fibrinogen deficiency (hypofibrinogenemia or afibrinogenemia) with a tendency to bleed.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Riastap

The following sections contain information that your doctor should consider before administering Riastap to you.

Do not use Riastap:

  • if you are allergic to human fibrinogen or to any of the other components of this medicine (listed in section 6).

Tell your doctor if you are allergic to any medicine or food.

Warnings and precautions:

  • If you have had allergic reactions to Riastap in the past. You should take antihistamines and corticosteroids as prophylaxis if your doctor recommends it.

When allergic reactions or anaphylactic reactions (severe allergic reaction that causes severe breathing difficulties or dizziness) occur. The administration of Riastap should be interrupted immediately (e.g., by stopping the injection).

  • Due to a high risk of blood clots forming in a blood vessel (thrombosis), particularly:
  • in case of administration of a high dose or repeated doses,
  • if you have had a heart attack (history of coronary artery disease or myocardial infarction),
  • if you have liver disease,
  • if you have recently undergone surgery (postoperative patients),
  • if you are about to undergo surgery (preoperative patients),
  • in newborns (neonates),
  • if you have a higher than normal risk of blood clots (patients with a risk of thromboembolic events or disseminated intravascular coagulation).

Your doctor will need to carefully weigh the benefits of treatment with Riastap against the risks of these complications.

Viral safety

When medicines are manufactured from human blood or plasma, certain measures are taken to prevent the transmission of infections to patients. These measures include:

  • careful selection of blood and plasma donors to ensure that donors at risk of carrying infections are excluded, and
  • testing of each individual donation and of plasma pools for signs of viruses and infections.

In addition, manufacturers of these products include measures during blood or plasma processing to inactivate or remove viruses. Despite these measures, when medicines are administered that are made from human blood or plasma, the possibility of transmitting infections cannot be completely excluded. This applies to any emerging or unknown virus or other types of infections.

The measures taken are considered effective for enveloped viruses such as human immunodeficiency virus (HIV, the AIDS virus), hepatitis B virus, and hepatitis C virus (liver inflammation), and for non-enveloped viruses such as hepatitis A virus (liver inflammation) and parvovirus B19.

Your doctor may recommend that you be vaccinated against hepatitis A and B if you regularly or repeatedly receive medicines made from human plasma.

It is strongly recommended that every time Riastap is administered, a record is kept of the date of administration, the batch number, and the volume injected.

Taking Riastap with other medicines

  • Tell your doctor or pharmacist if you are using or have recently used or might use any other medicines.
  • Riastap should not be mixed with other medicines, except those mentioned in the section "This information is intended for healthcare professionals only".

Pregnancy and breastfeeding

  • If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
  • During pregnancy and breastfeeding, Riastap should only be used if clearly indicated.

Driving and using machines

Riastap has no or negligible influence on the ability to drive and use machines.

Important information about some of the ingredients of Riastap

Riastap contains up to 164 mg (7.1 mmol) of sodium per vial. This corresponds to 11.5 mg (0.5 mmol) of sodium per kilogram of body weight of the patient, if the recommended initial dose of 70 mg/kg body weight is administered. Please note this if you are on a controlled sodium diet.

3. How to use Riastap

Treatment should be initiated and supervised by a doctor experienced in the treatment of this type of disorder.

Dosage

The amount of human fibrinogen you need and the duration of treatment depend on:

  • the severity of your disease
  • the location and intensity of the bleeding
  • the patient's clinical situation

If you take more Riastap than you should

During treatment, your doctor should regularly check the coagulation status of your blood. In case of overdose, the risk of developing thromboembolic complications increases.

Method of administration

If you have any further questions on the use of this product, ask your doctor or pharmacist (see the section "This information is intended for healthcare professionals only").

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Please tell your doctor immediately:

  • if you get any side effects
  • if you notice any side effects not listed in this leaflet.

The following side effect is very common (may affect more than 1 in 10 people):

  • Increased body temperature

The following side effect has been observed uncommonly (may affect up to 1 in 100 people):

  • A sudden allergic reaction (such as skin redness, erythema all over the body, blood pressure drop, difficulty breathing).

The following side effect has been observed frequently (may affect up to 1 in 10 people, however, the incidence was higher in patients who did not receive fibrinogen):

  • Risk of increased blood clot formation (see section 2 "What you need to know before you use Riastap").

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Agency's website: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

.

5. Storage of Riastap

  • Keep out of the sight and reach of children.
  • Do not use Riastap after the expiry date which is stated on the label and on the carton.
  • Do not store above 25°C.
  • Do not freeze.
  • Store the vial in its outer packaging to protect it from light.
  • The reconstituted solution should be used immediately.
  • If the reconstituted solution is not administered immediately, storage at room temperature (max. +25°C) should not exceed 8 hours.
  • Do not refrigerate the solution after reconstitution.

6. Further information

Composition of Riastap

The active substance is:

Human fibrinogen (1 g/vial; after reconstitution with 50 ml of water for injections, approx. 20 mg/ml).

If you need more information, see the section "This information is intended for healthcare professionals only".

The other ingredients are:

Human albumin, sodium chloride, L-arginine hydrochloride, sodium citrate dihydrate, sodium hydroxide (for pH adjustment).

See the last paragraph of section 2. "Important information about some of the ingredients of Riastap".

Appearance of Riastap and contents of the pack

Riastap is presented as a white powder.

After reconstitution with water for injections, the solution obtained should be clear or slightly opalescent, i.e., it may shine when held against the light, but it should not contain any particles.

Presentation

1 g pack (Figure 1)

  1. A vial with 1 g of human fibrinogen
  2. Pall filter needle
  3. Mini-Spike aspiration needle

Vial with lyophilized powder numbered as 1, blister with diluent numbered as 2 and pre-filled syringe on a tray numbered as 3 Figure 1

Marketing authorisation holder and manufacturer

CSL Behring GmbH

Emil-von-Behring-Strasse 76

35041 Marburg

Germany

Local representative:

CSL Behring, S.A.

c/ Tarragona 157, 18th floor

08014 Barcelona

Spain

This medicine is authorised in the Member States of the European Economic Area under the following names:

Riastap 1 g powder for solution for injection/infusion United Kingdom

Riastap 1g, powder for solution for injection/infusion France

Riastap 1g prašek za raztopino za injiciranje ali infundiranje Slovenia

Riastap 1 g Germany, Ireland

Riastap Belgium, Cyprus, Denmark, Finland, Greece, Iceland, Italy, Luxembourg, Malta, Norway, Poland, Slovakia, Spain, Sweden

Date of last revision of this leaflet:December 2023

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.es/

This information is intended for healthcare professionals only:

Dosage

The level of fibrinogen (functional) should be determined in order to calculate the individual dose and the amount and frequency of administration, which should be calculated for each patient through periodic measurement of the fibrinogen level in plasma and continuous monitoring of the patient's clinical situation and other substitute therapies applied.

The normal level of fibrinogen in plasma is within the range of 1.5 - 4.5 g/l. The critical level of fibrinogen in plasma below which there is a risk of bleeding is approximately 0.5 - 1.0 g/l. In case of major surgery, control of substitution therapy by coagulation tests is essential.

Initial dose

If the patient's fibrinogen level is not known, the recommended dose is 70 mg per kg of body weight, administered intravenously.

Subsequent doses

In mild cases (e.g., nosebleeds, muscle hemorrhage, or menorragia), the level to be achieved is 1 g/l, which should be maintained for at least three days. In severe cases (e.g., head trauma or intracranial hemorrhage), the level to be achieved is 1.5 g/l, which should be maintained for seven days.

Dose of fibrinogen = [Target level (g/l) - measured level (g/l)]

(mg/kg body weight) 0.017 (g/l per mg/kg body weight)

Dosing for neonates, infants, and children

Limited data are available from clinical studies on the dose of Riastap in children. As a result of these studies, as well as extensive clinical experience with fibrinogen-containing products, the recommended doses in the treatment of children are the same as those recommended for adults.

Method of administration

General instructions

  • Reconstitution and transfer should be performed under aseptic conditions.
  • Before administration, the reconstituted solutions should be visually inspected for foreign particles and discoloration.
  • The solution should be practically colorless or yellowish, clear or slightly opalescent, and have a neutral pH. Do not use cloudy solutions or those containing deposits.

Reconstitution

  • Allow the solvent and powder in the vials to reach room temperature or body temperature (not above 37°C) without opening.
  • Riastap should be reconstituted with water for injections (50 ml, not included).
  • Wash your hands or use gloves before reconstituting the product.
  • Remove the cap from the Riastap vial, exposing the central surface of the infusion stopper.
  • Treat the surface of the infusion stopper with an antiseptic and let it dry.
  • Transfer the solvent with a suitable transfer device into the vial, ensuring complete wetting of the powder.
  • Gently swirl the vial until the powder is completely dissolved and the solution is ready for administration. Avoid vigorous shaking as this may cause foam formation. The powder usually dissolves in approximately 5 minutes. It should not take more than 15 minutes to dissolve completely.
  • Open the plastic blister containing the Mini-Spike aspiration needle provided with Riastap (Figure 2).

Hand with glove holding a transparent glass ampoule and breaking the top with a silver metal device Figure 2

  • Take the aspiration needle provided and insert it into the stopper of the vial with the reconstituted product (Figure 3).

Hand with glove holding a transparent glass vial and a black syringe connected to its top stopper Figure 3

  • After inserting the aspiration needle, remove the cap. After removing the cap, do not touch the exposed surface.
  • Open the blister containing the Pall filter needle provided with Riastap (Figure 4).

Hand with glove holding an insulin applicator with a needle inserted into a fold of abdominal skin Figure 4

  • Screw the syringe onto the filter (Figure 5).

Hand with glove holding a transparent syringe with a numerical scale and preparing for injection into the skin Figure 5

  • Screw the syringe with the mounted filter onto the aspiration needle (Figure 6).

Hand with glove holding a syringe over a transparent vial with liquid, preparing for withdrawal Figure 6

  • Aspirate the reconstituted product into the syringe (Figure 7).

Hand holding a transparent glass cylinder with liquid and connected to a transparent syringe with a visible plunger Figure 7

  • When finished, remove the filter, the aspiration needle, and the empty vial from the syringe, dispose of them properly, and continue with the administration in the usual manner.
  • The reconstituted product should be administered immediately through a separate injection/infusion line.
  • Be careful not to let blood enter the syringes containing the product.

Administration

For intravenous administration, at room temperature, the use of a standard infusion kit is recommended. Inject or infuse the reconstituted solution slowly intravenously at a comfortable speed for the patient. The injection or infusion rate should not exceed 5 ml per minute.

Online doctors for RIASTAP 1 g POWDER FOR INJECTABLE SOLUTION OR INFUSION

Discuss questions about RIASTAP 1 g POWDER FOR INJECTABLE SOLUTION OR INFUSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

Doctor
5.0(38)

Andrei Popov

General medicinePain medicine7 years of experience

Dr. Andrei Popov is a General Practitioner with specialized training in chronic pain. He provides online consultations for adult patients in Spain and other European countries.

Dr. Popov understands that seeking help with weight-related concerns or pain that has persisted for months can be difficult. Many patients come to him after trying different approaches without feeling truly heard. During the consultation, the doctor creates a comfortable and supportive, non-judgmental environment where the patient’s medical history can be discussed in detail, questions can be answered, and the next steps can be decided together.

Weight Management and Metabolic Health

Dr. Popov can help assess overweight, obesity, and related conditions such as hypertension, diabetes, or metabolic disorders. During the consultation, the patient’s medical history, test results, current medications, and previous treatments will be reviewed.

If you would like to learn about possible medication options or have already started treatment, the doctor can assess your situation, review the effectiveness and tolerability of the therapy, and clearly explain its benefits, potential risks, and alternatives.

Not every patient requires the same treatment. A consultation does not guarantee a prescription — it provides an objective medical assessment and a plan tailored to your individual situation.

Pain and General Medicine

You can also consult Dr. Popov regarding:

* chronic pain, migraines, neuralgia, and fibromyalgia;

* back, neck, lower back, or joint pain;

* hypertension, diabetes, and follow-up of chronic conditions;

* review of test results, medical reports, and current treatment;

* preventive medicine and a second medical opinion.

How the Consultation Works

The video consultation lasts up to 30 minutes. The doctor will listen carefully, review the information you provide, and explain the next steps in clear and understandable language.

If additional tests, an in-person consultation, or urgent medical care are required, the doctor will inform you directly.

Dr. Popov’s goal is to make sure the patient feels heard and leaves the consultation with a clear understanding of their condition and the next steps they can take.

Book a video appointment
€86
Doctor
5.0(12)

Yevgen Yakovenko

General medicine12 years of experience

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Book a video appointment
€72
Doctor
5.0(3)

Lina Travkina

General medicine13 years of experience

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.

  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.

  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.

  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.

  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.

  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.

  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.

  • Medical advice and follow-up consultations.

  • Test interpretation and diagnostic guidance.

  • Structured support for undiagnosed complaints.

  • Second opinion on diagnoses and treatment plans.

  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.

  • Post-operative recovery support and pain management.

  • Preconception counselling and postpartum support.

  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Book a video appointment
€75
Doctor
5.0(20)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor
0.0(0)

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64

Get RIASTAP 1 g POWDER FOR INJECTABLE SOLUTION OR INFUSION Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

RIASTAP 1 g POWDER FOR INJECTABLE SOLUTION OR INFUSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in RIASTAP 1 g POWDER FOR INJECTABLE SOLUTION OR INFUSION is fibrinogen, human. This information helps identify medicines with the same composition but different brand names.

RIASTAP 1 g POWDER FOR INJECTABLE SOLUTION OR INFUSION is manufactured by Csl Behring Gmbh. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether RIASTAP 1 g POWDER FOR INJECTABLE SOLUTION OR INFUSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy RIASTAP 1 g POWDER FOR INJECTABLE SOLUTION OR INFUSION in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

Other medicines with the same active substance (fibrinogen, human) include FIBCLOT 1.5 g POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION, FIBRYGA 1 g POWDER AND SOLVENT FOR INJECTABLE SOLUTION AND FOR INFUSION, ADVATE 1,000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media